Medicine for treating nasal cavity disease and preparation thereof

A disease and drug technology, applied in the field of drugs for the treatment of nasal cavity diseases, can solve the problems of large dosage, long treatment cycle, and insignificant curative effect, and achieve the effect of safe use, simple and convenient use method, and direct therapeutic effect

Inactive Publication Date: 2007-03-07
裴志勇
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are also the disadvantages of slow drug action time, long treatment cycle, large dosage, and insignificant curative effect, and side effects such as drowsiness are prone to occur after taking the drug.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0018] Weigh the raw materials according to the following ratio:

[0019] Sophora flavescens 1500g; Magnolias 600g;

[0020] Cork 900g; Mint 150g.

[0021] The specific production method is as follows:

[0022] Add Sophora flavescens, magnolia, Cortex Phellodendron, and peppermint to the extraction tank, add water to decoct for 2 hours, filter, add water to the residue and decoct for 2 hours, filter, discard the residue, and combine the filtrate; extract the filtrate with 2 times the volume of ethanol, discard Concentrate the residue by heating and collect ethanol to obtain a solution with a relative density of 1.02 at 20°C; add 1.5g of disodium itamate to the solution and stir for 30min, then add 0.75g of ethylparaben and stir for 10min; add dropwise 2% boric acid solution The pH value of the solution is adjusted to 5.5-7.5, and the solution is filled into a spray bottle to obtain a spray product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicinal composition for treating nasal diseases, which is prepared from Chinese medicinal herbs including flavescent sophora root, flower bud of lily magnolia, corktree bark and peppermint through through extracting, concentrating, charging right amount of anti-oxidant and preservative.

Description

Technical field [0001] The invention relates to a medicine for treating nasal cavity diseases, in particular to a medicine for treating nasal cavity diseases prepared from traditional Chinese medicine. The invention also relates to a preparation method of the medicine. Background technique [0002] There are many ways to treat nasal cavity inflammation. Surgical therapy is difficult to be accepted by patients because of its great pain and trauma. Western medicine such as Dripping Bijing has the effect of constricting blood vessels, and the short-term curative effect is very fast, and it can take effect immediately, but once the medicine is stopped, rhinitis will recur immediately, and the side effects of western medicine are relatively large, and long-term use may lead to atrophic rhinitis. big limit. Oral pure Chinese medicine preparations have a lot of drug reports for the treatment of rhinitis, such as Chinese patents 93103946, 94101473, 03128114, etc., all disclose ora...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/756A61P11/02
Inventor 张海裴志勇张亚平
Owner 裴志勇
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products